# EDGAR Filing Document

**Accession Number:** 0001615055
**File Stem:** 0001140361-23-015127
**Filing Date:** 2023-3
**Character Count:** 3555
**Document Hash:** 84b52f48dffbe3963a8d2b2c195a6fce
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-23-015127.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001140361-23-015127

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**EFFECTIVENESS DATE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IsoPlexis Corp
- **CENTRAL INDEX KEY:** 0001615055
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **IRS NUMBER:** 462179799
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40894
- **FILM NUMBER:** 23783448

**BUSINESS ADDRESS:**
- **STREET 1:** 35 NE INDUSTRIAL ROAD
- **CITY:** BRANFORD
- **STATE:** CT
- **ZIP:** 06405
- **BUSINESS PHONE:** 203-208-4111

**MAIL ADDRESS:**
- **STREET 1:** 35 NE INDUSTRIAL ROAD
- **CITY:** BRANFORD
- **STATE:** CT
- **ZIP:** 06405

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

#### <br>

### FORM 15

------

#### <br>

#### CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

#### UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

#### OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

#### OF THE SECURITIES EXCHANGE ACT OF 1934.

#### Commission File No. 001-40894

------

#### <br>

## IsoPlexis Corporation

#### (Exact name of registrant as specified in its charter)

------

#### <br>

#### 35 NE Industrial Road

#### Branford, Connecticut 06405
(203) 208-4111

#### (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

#### Common Stock, par value $0.001 per share

#### (Title of each class of securities covered by this Form)

#### None

#### (Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: |
| Rule 12g-4(a)(1) | ☒ |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | ☒ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☐ |
| Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date: One (1).\*

\*On March 21, 2023, pursuant to that certain Agreement and Plan of Merger, dated as of December 21, 2022, by and among Berkeley Lights, Inc., a Delaware corporation ("Berkeley Lights"), Iceland Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Berkeley Lights ("Merger Sub"), and IsoPlexis Corporation, a Delaware corporation (the "Company"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Berkeley Lights.

------

Pursuant to the requirements of the Securities Exchange Act of 1934, IsoPlexis Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | |
|:---|:---|
| Date: March 31, 2023 |  |
|  | **ISOPLEXIS CORPORATION** |
|  | /s/ Scott Chaplin |
|  | Name: Scott Chaplin |
|  | Title: Chief Legal Officer |

---

------